Nanotechnology in Targeted Drug Delivery in Medical Theranostics: From Lab to Bed

Author(s): Ali Yadollahpour

Journal Name: Current Topics in Medicinal Chemistry

Volume 20 , Issue 30 , 2020


Become EABM
Become Reviewer
Call for Editor

[1]
Zhang, W.; Wang, W.; Yu, D.X.; Xiao, Z.; He, Z. Application of nanodiagnostics and nanotherapy to CNS diseases. Nanomedicine (Lond.), 2018, 13, 2341-2371.
[2]
El-Sayed, A.; Kamel, M. Advances in nanomedical applications: Diagnostic, therapeutic, immunization, and vaccine production. Environ. Sci. Pollut. Res., 2020, 27, 19200-19213.
[3]
Yadollahpour, A. Magnetic nanoparticles in medicine: A review of synthesis methods and important characteristics. Orient. J. Chem., 2015, 31, 271-277.
[4]
Pérez-Herrero, E.; Fernández-Medarde, A. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. Eur. J. Pharm. Biopharm., 2015, 93, 52-79.
[5]
Debbage, P. Targeted drugs and nanomedicine: Present and future. Curr. Pharm. Des., 2009, 15, 153-172.
[6]
Yadollahpour, A.; Rashidi, S. Magnetic nanoparticles: A Review of chemical and physical characteristics important in medical applications. Orient. J. Chem., 2015, 31, 25-30.
[7]
Ali, Y.; Zohre, R.; Mostafa, J.; Samaneh, R. Applications of upconversion nanoparticles in molecular imaging: A review of recent advances and future opportunities. Biosci. Biotechnol. Res. Asia, 2015, 12, 131-140.
[8]
Wolfram, J.; Ferrari, M. Clinical cancer nanomedicine. Nano Today, 2019, 25, 85-98.
[9]
Yadollahpour, A.; Asl, H.M.; Rashidi, S. Applications of nanoparticles in magnetic resonance imaging: A comprehensive review. Asian J. Pharma., 2017, 11, S7-S13.
[10]
Wu, X.; Liu, H.; Liu, J.; Haley, K.N.; Treadway, J.A.; Larson, J.P.; Ge, N.; Peale, F.; Bruchez, M.P. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat. Biotechnol., 2003, 21, 41-46.
[11]
Reulen, S.W.A.; Brusselaars, W.W.T.; Langereis, S.; Mulder, W.J.M.; Breurken, M.; Merkx, M. Protein-liposome conjugates using cysteine-lipids and native chemical ligation. Bioconjug. Chem., 2007, 18, 590-596.
[12]
Jha, S.; Mathur, P.; Ramteke, S.; Jain, N.K. Pharmaceutical potential of quantum dots. Artif. Cells Nanomed. Biotechnol., 2018, 46, 57-65.
[13]
Ali, Y.; Zohre, R.; Mostafa, J.; Samaneh, R. Dye-doped fluorescent nanoparticles in molecular imaging: A review of recent advances and future opportunities. Material Science Research India, 2014, 11(2), 102-113.
[14]
Kevadiya, B.D.; Ottemann, B.M.; Thomas, M.; Mukadam, I.; Nigam, S.; McMillan, J.; Gorantla, S.; Bronich, T.K.; Edagwa, B.; Gendelman, H.E. Neurotheranostics as personalized medicines. Adv. Drug Deliv. Rev., 2019, 148, 252-289.
[15]
Schneider, C.S.; Perez, J.G.; Cheng, E.; Zhang, C.; Mastorakos, P.; Hanes, J.; Winkles, J.A.; Woodworth, G.F.; Kim, A.J. Minimizing the Non-specific binding of nanoparticles to the brain enables active targeting of Fn14-positive glioblastoma cells. Biomaterials, 2015, 42, 42-51.
[16]
Li, W.; Wei, H.; Li, H.; Gao, J.; Feng, S.S.; Guo, Y. Cancer nanoimmunotherapy using advanced pharmaceutical nanotechnology. Nanomedicine, 2014, 9, 2587-2605.
[17]
Rabinovich, G.A.; Gabrilovich, D.; Sotomayor, E.M. Immunosuppressive strategies that are mediated by tumor cells. Annu. Rev. Immunol., 2007, 25, 267-296.
[18]
Lu, X.; Perera, T.H.; Aria, A.B.; Callahan, L.A.S. Polyethylene glycol in spinal cord injury repair: A critical review. J. Exp. Pharmacol., 2018, 10, 37-49.
[19]
Dennis, S.C.; Whitlow, J.; Detamore, M.S.; Kieweg, S.L.; Berkland, C.J. Hyaluronic-acid-hydroxyapatite colloidal gels combined with micronized native ECM as potential bone defect fillers. Langmuir, 2017, 33, 206-218.
[20]
Marycz, K.; Smieszek, A.; Trynda, J.; Sobierajska, P.; Targonska, S.; Grosman, L.; Wiglusz, R.J. Nanocrystalline hydroxyapatite loaded with resveratrol in colloidal suspension improves viability, metabolic activity and mitochondrial potential in human adipose-derived mesenchymal stromal stem cells (HASCs). Polymers (Basel), 2019, 11(1), 92.
[21]
Gupta, A.K.; Gupta, M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials, 2005, 26, 3995-4021.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 20
ISSUE: 30
Year: 2020
Page: [2735 - 2736]
Pages: 2
DOI: 10.2174/156802662030201110091740

Article Metrics

PDF: 29
HTML: 2